Fresenius To Pay $50M For Impeding FDA Investigation
Law360 (February 9, 2021, 7:14 PM EST) -- Indian drug manufacturer Fresenius Kabi Oncology Ltd. will plead guilty and pay $50 million to end claims that it destroyed and hid records related to the production of cancer drugs before a 2013 investigation by the U.S. Food and Drug Administration, the U.S. Department of Justice announced Tuesday.
The DOJ charged FKOL in Nevada federal court with violating the Federal Food, Drug and Cosmetic Act for failing to turn over certain documents requested by the FDA, prosecutors said in a release. The case was unsealed this week, although the criminal information was not immediately available in the public docket Tuesday....
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!